CareLit · DOI-Nachweis · Klinische Pädiatrie
Combined Linkage and Association Studies of Antibodies against EBV Antigens Confirm the Role of HLA Class II Variants in the Control of Anti-EBNA1 IgG Levels and in the Risk of Hodgkin's Lymphoma
DOI 10.1055/s-0034-1371107
Bibliografische Angaben
Nachweis in CareLit
Autor:innenV Pedergnana, L Syx, A Cobat, J Guergnon, P Brice, C Ferme, P Carde, O Hermine, C Le Pendeven, C Amiel, I Theodorou, L Abel, C Besson
ZeitschriftKlinische Pädiatrie
Ausgabe03/2014
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
An altered anti-EBV serologic profile is associated with an increased risk of Hodgkin's lymphoma (HL) and has been shown to precede HL diagnosis. Recent studies have provided evidence for the role of genetic factors controlling both anti- viral capsid antigen (VCA) and anti- Epstein-Barr nuclear antigen-1 (EBNA-1) immunoglobulin (Ig)G levels. Here, we conducted linkage and association studies to further search for g…
Zitieren
Zitierempfehlung
V Pedergnana, L Syx, A Cobat, J Guergnon, P Brice, C Ferme, P Carde, O Hermine, C Le Pendeven, C Amiel, I Theodorou, L Abel, C Besson (2014) Combined Linkage and Association Studies of Antibodies against EBV Antigens Confirm the Role of HLA Class II Variants in the Control of Anti-EBNA1 IgG Levels and in the Risk of Hodgkin's Lymphoma. Klinische Pädiatrie (03). https://doi.org/10.1055/s-0034-1371107
Mit CareLit weiterarbeiten